SciELO - Scientific Electronic Library Online

 
vol.23 número6Principales motivos de ingreso hospitalario en pacientes con enfermedad de Parkinson y su relación con los días de hospitalizaciónAsociación entre las complicaciones inducidas por la dopamina y la satisfacción vital en la enfermedad de Parkinson índice de autoresíndice de materiabúsqueda de artículos
Home Pagelista alfabética de revistas  

Servicios Personalizados

Revista

Articulo

Indicadores

Links relacionados

  • No hay artículos similaresSimilares en SciELO

Compartir


Revista mexicana de neurociencia

versión On-line ISSN 2604-6180versión impresa ISSN 1665-5044

Rev. mex. neurocienc. vol.23 no.6 Ciudad de México nov./dic. 2022  Epub 24-Ene-2023

https://doi.org/10.24875/rmn.22000018 

Original articles

Neutrophils/lymphocytes index compared to mean platelets volume/platelets count index, as long hospital stays and survival indicator of stroke. How much is little?

Índice de neutrófilos/linfocitos en comparación con MPV/PC, así como estancias hospitalarias prolongadas e indicador de supervivencia de eventos cerebrovasculares. ¿Cuánto es poco?

Juan J. Gómez Piña1  * 

Amairani Sierra Hernandez1 

1Hospital de especialidades “Dr. Antonio Fraga Mouret”, Centro Médico Nacional La Raza del Instituto Mexicano del Seguro Social, CDMX, Mexico


Abstract

Introduction:

Stroke is one of the main causes of disability in elderly, and the main cause of neurological emergencies. Mean platelet volume (MPV) has a positive correlation with prothrombotic diseases, highlighting thrombotic events and venous thrombosis disease.

Aim:

We aim to determine the relation between neutrophil/lymphocyte (N/L) index and MPV/platelet count (PC) index with prognosis in cerebral vascular events in the Mexican population.

Methods:

We included 236 patients with 137 males (74-78 years) and 81 females (64-72 years); 58 hemorrhagic cases, 44 parenchymal, eight subarachnoid, and 6 subdural; 160 ischemic cases, including 149 ischemic, 2 lacunar, and 9 Transient Ischemic Attack (TIA). All patients had brain imaging, initial, and follow-up hematic cytometry to determine indexes and compare it between them.

Results:

Neutrophils/lymphocytes index lower than 3 (p = 0.015) and MPV/PC index higher than 0.031 (p = 0.001) increase significantly in stroke during the first 48 h. MPV > 10 fl increase mortality (p = 0.014); considering all strokes; receiver operating characteristic curve showed AUC values of MPV/PC 0.822 (0.760-0.885) (p = 0.001) and N/L 0.661 (0.579-0.742) (p = 0.001) with a significant difference between AUC values (p = 0.001).

Conclusions:

In our study, mortality rises in patients over 70 years old, especially in hemorrhagic events, females; and patients with higher N/L and MPV/PC indexes. The MPV/PC is better at predicting severity and long hospital stay in stroke compared to the N/L index. The high platelets levels are related to stroke as well as other studies before; however, this is related to the worst prognosis, increasing mortality and long hospital stay in our population.

Keywords Mean platelet volume; Neutrophils lymphocytes ratio; Neutrophils/lymphocytes; Stroke; Mortality

Resumen

Introducción:

Los eventos vasculares cerebrales (EVC) son una de las principales causas de discapacidad en los adultos, además de ser la principal emergencia neurológica. El VPM tiene una correlación positiva con enfermedades protrombóticas, destacando los eventos cerebrovasculares trombóticos y la enfermedad de trombosis venosa.

Objetivo:

Determinar la asociación del índice N/L (Neutrófilo/Linfocito) y el índice VPM/PT (Volumen Plaquetario Medio/Plaquetas totales) con el pronóstico de población mexicana con EVC.

Métodos:

El estudio actual incluyó a 236 pacientes, incluidos 137 hombres (74-78 años) y 81 mujeres (64-72 años); se desarrollaron 58 eventos hemorrágicos, incluidos 44 parenquimatosos, 8 subaracnoideos y 6 subdurales; así como 160 eventos isquémicos, incluidos 149 isquémicos, 2 lacunares y 9 AIT (Ataque Isquemico Transitorio). A todos los pacientes se les realizaron tomografía de cráneo así como biometría hemática inicial y de seguimiento, determinando ambos índices y comparándolos entre ellos.

Resultados:

El índice de neutrófilos/linfocitos menor a 3 (p = 0.015) y un índice de plaquetario medio/plaquetas totales mayor a 0.031 (p = 0.001) aumentaron significativamente en pacientes con EVC durante las primeras 48 horas del evento. Mientras que valores mayores a 10 fl de VPM se asociaron l incremento de mortalidad (p = 0.014); considerando todos los EVC. La curva ROC mostró área bajo la curva de la relación VPM/PT 0.822 (0.760-0.885) (p = 0.001) y neutrófilos/linfocitos 0.661 (0.579-0,742) (p = 0.001) con una diferencia significativa entre los valores de área bajo la curva (p = 0.001).

Conclusiones:

La mortalidad es mayor en pacientes mayores de 72 años, en EVC hemorrágico, pacientes mujeres, así como aquellos con valores altos de índices neutrófilos/linfocitos y VPM/PT; el índice VPM/PT es mejor que el índice neutrófilos/linfocitos como marcador de gravedad en EVC, relacionado con mayores días de estancia intrahospitalaria. Estos índices podrían utilizarse para predecir la mortalidad y estancia prolongada en pacientes con EVC.

Palabras clave VPM; INL; Neutrófilos/linfocitos; EVC; Mortalidad

Introduction

Stroke occurs when blood perfusion is reduced, leading to neuron death; ischemic events present around 85% and hemorrhagic in 15%. Ischemic events are classified into embolic, thrombotic, or lacunar1. Although hypertensive decontrol is the main etiology, some others as clotting disorders, carotid dissection, or drugs must be investigated2.

Chronic inflammation led to higher platelet levels and lower lymphocytes levels, increasing the risk of stroke events3. Platelets reflect inflammation, and the mean platelet volume (MPV) express platelet activation, this marker is elevated in stroke and is associated with poor outcome; on the other hand, the level of platelet count (PC) is inversely proportional to MPV in stroke, this might be related to the increasing consumption in the process of thrombus formation4.

The MPV/PC index is a better indicator of inflammation and platelet activation compared to MPV or PC alone5. This inflammation is even found in some tumors, including hepatocellular carcinoma, pancreatic cancer, and lung cancer, increasing the MPV/PC index6.

High levels of MPV and neutrophils lymphocytes ratio (NLR) are found in carotid artery stenosis and cardiac arrest7. However, NLR and MPV are higher when carotid artery stenosis is between 70 and 99%7.

Platelet size plays an important role as a cardiovascular risk factor, while NLR and platelet/lymphocyte index express systemic inflammation8. Low platelets levels are related to thrombosis events, increasing cardiac events and mortality9. Furthermore large platelets are more reactive than small platelet10.

Previously some other indexes were studied, specially the MPV, NLR, and erythrocyte sedimentation rate (ESR) which are related with C-reactive protein (CRP) in stroke events; males keep better relation between CRP/NLR and ESR indexes, while females have a good relation between CRP/MPV and NLR/ESR indexes11.

The MPV expresses platelet production and inflammation, increasing the prothrombotic events12. However, there is a direct relation between platelet size in cardiovascular events, increasing the cardiovascular risk in patients with large platelets8.

The MPV and MPV/PC are higher in stroke events, even in patients who suffered cardiac arrest or post-AMI stroke13. Opposite to acute inflammation, lower levels of MPV express chronic inflammation and rheumatic diseases14. The increase in MPV and NLR/PLT predicts severity of stroke and TIA at admission and after 3 months15.

Despite the fact that MPV increases in stroke events, this may be increased in other diseases such as hypertension, diabetes, and atrial fibrillation, increasing the risk of stroke16. The MPV predicts outcomes in stroke events, and even during the following 90 days after thrombolysis events17. The MPV is higher in acute non-lacunar than lacunar ischemic strokes, and this is directly related to the MPV and lesion size18.

The high platelet levels are increased in all cardiovascular events, especially in myocardial infarction and ischemic stroke, this fact increases mortality in all stroke events19. The MPV, as an expression of platelets activation, is useful for prognosis of cardiovascular and stroke20. On the other hand, platelets activation expresses inflammation which produces brain damage and leads to spread microvascular dysfunction, edema enlargement, and eventually worsen functional outcomes21; this is reflected with higher MPV levels, which are found in all stroke types22.

Methods

This is a cross-sectional study that was done during the period from April 2020 to January 2022. Patients with ages over 18 years old were included into the analysis, including all types of strokes, demonstrated with imaging study (brain tomography or brain magnetic resonance) during the first 48 h of the event, with hematic cytometry at hospital admission, and interned into any hospital service. Hemorrhagic events were considered as stroke; however, just ischemic events were considered in the final analysis. We collect laboratory parameters from all hematic cytometry of WBC, MPV, neutrophils, lymphocytes, platelets; demographic parameters, sex, age; and stroke events, type of stroke, hospital stay days, hospital stay until discharge, die, or alive. All these parameters were analyzed and we obtained a relation between number of neutrophils and lymphocytes (N/L), which were considered normal with values between 0.78 and 3.53, and was divided into three three groups, low risk < 1.5, intermediate risk 1-5-3, and high risk > 3. The VPM was considered normal with values from 7 to 10 fl, a relation between VMP and platelets count was obtained, with a VPM/PC index was normal if the relation was lower than 0.031. Hematic cytometry was collected at admission and during hospitalization. Kaplan–Meier survival statistics and the log-rank test were used to compare stroke events according to sex, N/L, and MPV/PC index and type of stroke. A plot for comparison of receiver operating characteristic curve (ROC) curves among MPV/PC and N/L index was done. All the tests were two-sided and p-value < 0.05 was considered significant. All analyses were done using SPSS 20.0 (SPSS, Inc., Chicago, IL, USA).

Results

We collected 236 patients including 137 males (74-78 years) and 81 females (64-72 years); with 58 hemorrhagic cases, including 44 parenchymal, eight subarachnoid, and six subdural; and 160 ischemic cases, including 149 ischemic, 2 lacunar, and 9 TIA. Only 18 patients were discharged to other health-care centers, excluding these patients from final analysis. A neutrophils/lymphocytes index lower than 3 (p 0.015) had a 68.4% of sensitivity and 83.2% of specificity, with a PPV of 72% and NPV of 89%; and a MPV/PC index higher than 0.031 (p = 0.001) with a 71.2% of sensitivity and 84.9% of specificity, with a PPV of 62% and NPV of 94%; both indexes increased significantly in stroke patients during the first 48 h from the event, increasing hospital stay days at medium of 15 days (13-18 days). The correlation between serum parameters and mortality in stroke according to sex group is presented in Kaplan–Meier graph (Fig. 1). Values > 10 fl of MPV were found to increase significantly in dead patients (p = 0.014); considering all strokes, a total of 37 patients died (63.7%) because of a hemorrhagic event, and 92 (57.5%) because ischemic event, this mainly related to complications of long hospital stay. However, both indexes had a good specificity to predict mortality and long stay days in ischemic events, being useless in hemorrhagic events; ROC analysis showed that areas under the curve (AUC) values were MPV/PC 0.822 (0.760-0.885) (p = 0.001) and N/L 0.661 (0.579-0.742) (p = 0.001) with a significant difference between AUC values (p = 0.001).

Figure 1 A: Kaplan–Meier plots showing. Increase in mortality in patients with neutrophils/lymphocytes index lower than 3. B: increase in mortality in patients with MPV/PC index higher than 0.031. C: increase in mortality in patients with hemorrhagic stroke, compared to ischemic stroke. D: mortality according to sex. E: increase in mortality of patients with levels higher than 10 fl of MPV. F: ROC curve comparing MPV/PC and neutrophils/lymphocytes indexes predicting mortality. 

Discussion

The relation between platelets and thrombotic events is well studied; however, platelets play an important role in inflammation, it has been reported that MPV is a good indicator of platelet size and activity, helping as an inflammatory marker in cardiovascular events and stroke23. However, the MPV values are useful as the severity index of stroke, while the N/L index helps to express systemic inflammation24. Thereby leukocytes help into the atheroma formation; while leukocytosis is involved into plaque destabilization, inducing acute thrombotic events as stroke events, so lower N/L index could be related with a good prognosis. We found that the N/L index was significantly lower, while the MPV/PC index was higher during the first 48 h of stroke; these indexes can help to distinguish between systemic inflammation and local thrombosis mainly during the first 48 h of the event; however, both indexes are an independent predictor of long hospital stay and morality in stroke patients, even ischemic events had a high mortality, the hemorrhagic events are still the more lethal events, so MPV/PC and N/L indexes are useless to predict mortality in those events.

The clinical data showed that patients with in-hospital strokes were more likely to have long hospital stay days and high mortality; this is directly related to high MPV levels, as well as, high MPV/PC index, and lower N/L index, which were found in our study population during stroke events. The main finding of our study relates to the association of N/L index and MPV/PC index as accessible and non-invasive indexes of prognosis in stroke patients.

REFERENCES

1. Writing Group Members, Mozaffarian D, Benjamin EJ, Go AS, Arnett DK, Blaha MJ, et al. Heart disease and stroke statistics-2016 update:a report from the American heart association. Circulation. 2016;133:e38-60. [ Links ]

2. Nogueira RG, Jadhav AP, Haussen DC, Bonafe A, Budzik RF, Bhuva P, et al. Thrombectomy 6 to 24 hours after stroke with a mismatch between deficit and infarct. N Engl J Med. 2018;378:11-21. [ Links ]

3. Falk E. Pathogenesis of atherosclerosis. J Am Coll Cardiol. 2006;47:C7-12. [ Links ]

4. Fuentes QE, Fuentes QF, Andrés V, Pello OM, De Mora JF, Palomo GI. Role of platelets as mediators that link inflammation and thrombosis in atherosclerosis. Platelets. 2013;24:255-62. [ Links ]

5. Biricik S, NarcıH, Dündar GA, Ayrık C, Türkmenoğlu MÖ. Mean platelet volume and the ratio of mean platelet volume to platelet count in the diagnosis of acute appendicitis. Am J Emerg Med. 2019;37:411-4. [ Links ]

6. Gong X, Zhang L, Yang D, Xiao X, Wei L, Wu L, et al. Mean platelet volume/platelet count ratio is associated with prognosis in patients with pancreatic cancer. Int J Clin Exp Med. 2016;9:16379-86. [ Links ]

7. Deşer SB, Yucel SM, Demirag MK, Guclu MM, Kolbakir F, Keceligil HT. The association between platelet/lymphocyte ratio, neutrophil/lymphocyte ratio, and carotid artery stenosis and stroke following carotid endarterectomy. Vascular. 2019;27:604-11. [ Links ]

8. Carlioglu A, Timur O, Durmaz SA, Ayhan ME. Mean platelet volume in euthyroid patients with Hashimoto's thyroiditis. Blood Coagul Fibrinolysis. 2015;26:282-4. [ Links ]

9. Matthai WH Jr. Evaluation of thrombocytopenia in the acute coronary syndrome. Curr Opin Hematol 2010;17:398-404. [ Links ]

10. Bath PM, Butterworth RJ. Platelet size:measurement, physiology and vascular disease. Blood Coagul Fibrinolysis 1996;7:157-61. [ Links ]

11. Lee JH, Kwon KY, Yoon SY, Kim HS, Lim CS. Characteristics of platelet indices, neutrophil-to-lymphocyte ratio and erythrocyte sedimentation rate compared with C reactive protein in patients with cerebral infarction:a retrospective analysis of comparing hematological parameters and C reactive protein. BMJ Open. 2014;4:e006275. [ Links ]

12. Li JY, Li Y, Jiang Z, Wang RT, Wang XS. Elevated mean platelet volume is associated with presence of colon cancer. Asian Pac J Cancer Prevent. 2014;15:10501-4. [ Links ]

13. Guenancia C, Hachet O, Stamboul K, Béjot Y, Leclercq T, Garnier F, et al. Incremental predictive value of mean platelet volume/platelet count ratio in in-hospital stroke after acute myocardial infarction. Platelets. 2017;28:54-9. [ Links ]

14. Sahin A, Yetişgin A, şahin M, Durmaz Y, Cengiz AK. Can mean platelet volume be a surrogate marker of inflammation in rheumatic diseases?West Indian Med J. 2015;65:165-9. [ Links ]

15. Ghahremanfard F, Asghari N, Ghorbani R, Samaei A, Ghomi H, Tamadon M. The relationship between mean platelet volume and severity of acute ischemic brain stroke. Neurosciences (Riyadh). 2013;18:147-51. [ Links ]

16. Lippi G, Salvagno GL, Nouvenne A, Meschi T, Borghi L, Targher G. The mean platelet volume is significantly associated with higher glycated hemoglobin in a large population of unselected outpatients. Prim Care Diabetes. 2015;9:226-30. [ Links ]

17. Xie D, Xiang W, Weng Y, Li J, Xu L, Zhang X, et al. Platelet volume indices for the prognosis of acute ischemic stroke patients with intravenous thrombolysis. Int J Neurosci. 2019;129:344-9. [ Links ]

18. Gul SS, Gozke E. Mean Platelet Volume in Patients with Acute Ischemic Stroke with Nonvalvular Atrial Fibrillation. Clin Lab. 2018 Oct 31;64(11). [ Links ]

19. Patti G, Di Martino G, Ricci F, Renda G, Gallina S, Hamrefors V, et al. A. Platelet indices and risk of death and cardiovascular events:results from a large population-based cohort study. Thromb Haemost. 2019;119:1773-84. [ Links ]

20. Chu SG, Becker RC, Berger PB, Bhatt DL, Eikelboom JW, Konkle B, et al. Mean platelet volume as a predictor of cardiovascular risk:a systematic review and meta-analysis. J Thromb Haemost. 2010;8:148-56. [ Links ]

21. Shi K, Tian DC, Li ZG, Ducruet AF, Lawton MT, Shi FD. Global brain inflammation in stroke. Lancet Neurol. 2019;18:1058-66. [ Links ]

22. Bath P, Algert C, Chapman N, Neal B, PROGRESS Collaborative Group. Association of mean platelet volume with risk of stroke among 3134 individuals with history of cerebrovascular disease. Stroke. 2004;35:622-6. [ Links ]

23. Peng HX, Yang L, He BS, Pan YQ, Ying HQ, Sun HL, et al. Combination of preoperative NLR, PLR and CEA could increase the diagnostic efficacy for I-III stage CRC. J Clin Lab Anal. 2017;31:e22075. [ Links ]

24. Gökhan S, Özhasenekler A, Durgun HM, Akil E, Üstündag M, Orak M. Neutrophil lymphocyte ratios in stroke subtypes and transient ischemic attack. Eur Rev Med Pharmacol Sci. 2013;17:653-7. [ Links ]

FundingNone.

Ethical disclosures

Protection of human and animal subjects. The authors declare that no experiments were performed on humans or animals for this study.

Confidentiality of data. The authors declare that they have followed the protocols of their work center on the publication of patient data.

Right to privacy and informed consent. The authors declare that no patient data appear in this article.

Received: April 09, 2022; Accepted: August 22, 2022

* Correspondence: Dr. Juan José Gómez Piña E-mail: drjgomezp@gmail.com

Conflicts of interest

None.

Creative Commons License Instituto Nacional de Cardiología Ignacio Chávez. Published by Permanyer. This is an open access article under the CC BY-NC-ND license